Laser-capture-microdissection of tumor tissues followed by RT-PCR analysis suggested that in vivo NLGP treatment showed no change in melanoma (gp100) and dendritic cell (DC) (CD11c) marker, but an increase in macrophage marker (CD11b) (Figure 1C). Here, ITGAX is linked to neoplasm.